Comparative evaluation of the structure of cardiovascular diseases of the rural and urban population of the republic of uzbekistan, suffering from stage 5 CKD on programmed hemodialysis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. comparatively study the structure of cardiovascular pathology in patients with stage 5 ckd receiving programmed hemodialysis of the rural and urban population of the republic of Uzbekistan. material and methods. 165 patients with stage 5 ckd receiving hemodialysis were examined. patients were divided into two groups depending on their permanent place of residence: urban and rural. the study of patients from the urban population was carried out in two large republican centers in Tashkent and the rural population was studied in the regional multidisciplinary medical center in the city of gulistan. results. According to the results of the study, cardiovascular pathology was determined in 60% of the urban and 39% of the rural population. ah, ihd and hf prevailed in its structure in both groups. also, cvs comorbidity was found in both groups. Conclusion. According to the results of our study, patients in the urban population with CKD5D are more likely to suffer from cardiovascular disease than in the rural population. Comorbid cvs pathology occupies a leading place in the structure of cardiovascular pathology in patients with CKD5D in both urban and rural populations.

Full Text

Restricted Access

About the authors

Olimkhon N. Sharapov

Tashkent Pediatric Medical Institute; Republican Specialized Scientific and Practical Medical Center of Nephrology and Kidney Transplantation

Email: olimkhon@gmail.com
Doctoral Student at the Department of Faculty Internal Diseases, Occupational Pathology, Military Field Therapy, Hospital Internal Diseases and Propaedeutics of Internal Diseases; Nephrologist Tashkent, Uzbekistan

Botir T. Daminov

Tashkent Pediatric Medical Institute; Republican Specialized Scientific and Practical Medical Center of Nephrology and Kidney Transplantation

Email: nefrologiya2019@mail.ru
Doctor of Medical Sciences, Professor at the Department of Faculty Internal Diseases, Occupational Pathology, Military Field Therapy, Hospital Internal Diseases and Propaedeutics of Internal Diseases; Director Tashkent, Uzbekistan

S. V Yarygina

Republican Specialized Scientific Practical Medical Center of Urology

Email: info@rscu.uz
Doctor of the Highest Qualification Category, Head of the Department of Extracorporeal Detoxification Tashkent, Uzbekistan

V. A Dyagilev

Syrdarya Regional Multidisciplinary Medical Center

Email: sir.vkttm@mail.ru
Head of the Department of Nephrology and Hemodialysis Gulistan, Uzbekistan

References

  1. Levin A., Tonelli M, Bonventre J et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1888-917.
  2. Crews D.C., Bello A.K., Saadi G., et al. Burden, access, and disparities in kidney disease. Kidney Int. 2019;95:242-48.
  3. Jager K.J., et al. A single number for advocacy and communication - worldwide more than 850 million individuals have kidney diseases. Nephrol. Dial. Transplant. 2019;34(11):1803-805.
  4. ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2015. Academic Medical Center, Department of Medical Informatics, Amsterdam, the Netherlands. 2017.
  5. Tunbridge M.J., Jardine A.G. Cardiovascular complications of chronic kidney disease. Medicine. 2019;47(9):585-90.
  6. Gruberg L., et al. Comparison of outcomes after percutaneous coronary revascularization withstents in patients with and without mild chronic renal insufficiency. Am. J. Cardiol. 2002;89:54- 7.
  7. Levin A., Stevens P., et al. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. Suppl. 2013;3:1. doi: 10.1038/kisup.2012.48.
  8. Mancia G. Guidelinesfor the Management of Arterial Hypertension. J. Hypertens. 2007;25:1105-87.
  9. Tonelli M., et al. Chronic kidney diseaseand mortality risk: a systematic review. J. Am. Soc. Nephrol. 2006;17:2034-47.
  10. Henry R.M., et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int. 2002;62:1402-407.
  11. Meisinger C., et al. Сronic kidney disease and risk of incident myocardial infarction. Eur. Heart J. 2006;27:1245-50.
  12. Crews D.C, Bello A.K., Saadi G., et al. Burden, access, and disparities in kidney disease. Kidney Int. 2019;95:242-48.
  13. Hill N.R., Fatoba S.T., Oke J.L., et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11:e0158765.
  14. Sherwood M., McCullough P.A. Chronic kidney diseasefrom screening, detection and awaieners, to prevention. Lancet. Health. 2016;4(5):e288-89.
  15. George J.A., et al. Kidney damage and associated risk factors in rural and urban sub-Saharan Africa (AWI-Gen): a cross-sectional population study. Lancet. Glob. Health. 2019;7:e1632-43.
  16. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification / National Kidney Foundation. Am. J. Kidney Dis. 2002;39(1):1-266.
  17. National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am. J. Kidney Dis. 2015;66(5): 884-930.
  18. Аметов А.С., Курочкин И.О., Зубков А.А. Сахарный диабет и сердечно-сосудистые заболевания. РМЖ. 2014;13:954-63.
  19. Fouad S. Cost effectiveness of darbepoetin alfa versus epoetin alfa in the management of anemic patients with chronic kidney disease: health insurance perspective. Value in Health. 2016;19:A589.
  20. Будневский А.В., Овсянников Е.С., Редька А.В. Влияние анемии на течение сердечно-сосудистых заболеваний. Кардиоваск. терапия и профилактика. 2016;15(1):64-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies